NCT03786198.

Trial name or title	Activity progam during aromatase inhibitor therapy
Methods	RCT
Participants	350 participants, early breast cancer, on adjuvant AI
Interventions	Home‐based walking intervention vs physical activity according to standard recommendations
Outcomes	Primary outcome Incidence of muscle/joint symptoms by BPI‐SF Secondary outcomes Fatigue, EORTC QLQ‐C30 Nausea/vomiting, EORTC QLQ ‐ Breast Cancer Module (BR‐23) Severity of muscle/joint symptoms via BPI‐SF Walking activity Treatment adherence
Starting date	28 March 2019
Contact information	Daniele Oberti: +41313899191; trials@sakk.ch
Notes	Switzerland